ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
about
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaA Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastomaGenetics of Bladder Malignant Tumors in ChildhoodThe role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Recent insights into the biology of neuroblastoma.Maternal Immunization: New Perspectives on Its Application Against Non-Infectious Related Diseases in Newborns.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.TKI sensitivity patterns of novel kinase-domain mutations suggest therapeutic opportunities for patients with resistant ALK+ tumors.Report of neuroblastoma in a set of monozygotic monochorionic twins.Oncologic Phenotype of Peripheral Neuroblastic Tumors Associated With PHOX2B Non-Polyalanine Repeat Expansion Mutations.
P2860
Q24310296-3B9066CC-241E-451A-8C40-F35A17776407Q30252766-159B1B6F-CC95-45B8-B85B-053E73C0189BQ33757079-63572457-E7D3-40AC-9D04-350F6EB6305AQ35036462-3F0637B2-6473-45C9-BCE3-EAD1FACA092DQ36658484-44CA6833-859B-45C0-8262-D24664EE2C3EQ38070334-6912A7D5-B2F8-4A42-88F6-65BA46B0D83CQ38240010-8043380B-A186-44D4-8C55-1805DA5F6F44Q38649517-B7D0EEB6-D2BF-499F-A144-F444C86D798FQ38702196-A6F21266-955C-4603-984C-08FED09D4F59Q38855176-AC0131DF-7F56-4ED1-81C4-B683A89A2F66Q41133791-190F3793-14B4-4B4F-9F84-0D81A92B4A91Q44636777-7A482D32-652E-4D6A-901B-3BF25DE39262Q47936860-0A805C81-4C49-4A2E-9C1E-DD0B73BBE875
P2860
ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@ast
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@en
type
label
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@ast
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@en
prefLabel
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@ast
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@en
P2093
P2860
P50
P356
P1476
ALK germline mutations in pati ...... and weakly penetrant syndrome.
@en
P2093
Agnès Ribeiro
Bertrand Isidor
Comité Neuroblastome of the Société Francaise de Cancérologie
Gaëlle Pierron
Gudrun Schleiermacher
Jean Bénard
Jean Michon
Laurence Brugières
Ludovic Lacroix
Marjorie Hilbert
P2860
P2888
P304
P356
10.1038/EJHG.2011.195
P50
P577
2011-11-09T00:00:00Z
P5875
P6179
1022362882